~~<i id='77E99A47C9'><strike id='77E99A47C9'><tt id='77E99A47C9'><pre id='77E99A47C9'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

fashion

author：explore 2025-09-29 16:33:33 - browse：32153

Here at STAT, we spend a lot of time trying to imagine — and render — the invisible. We’ve gone inside of a developing embryo. We’ve flown inside our mouths to show the bacterial tribes that take root there. We’ve traveled through time and space to bring back to life a hallowed surgical theater. We’ve followed sound waves through our inner ears into our brains.

Of all of these fantastic journeys, one of the hardest subjects to capture, visually, has been CRISPR. Others have tried to capture the essence of the powerful gene-editing technique with the use of analogies.

Above, you can find our latest visual attempt to wrangle the genetic complexities of CRISPR into lively, and hopefully enjoyable, two minutes.

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： House looks to weaken Medicare negotiation

leisure time

knowledge

explore

leisure time

entertainment

BiogenCEOChristopherViehbacherSTATTwoyearsafterabigscientificswingnearlypushedBiogentothebrink,CEOCh

WSS

House looks to weaken Medicare negotiation

In search for therapies for solid tumors, companies turn to claudin

How AI can help patients find reliable information about doctors

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Flu vaccine offering decent levels of protection this winter, new data show

An inside look at PIPEs, biotech's buzzy new financing tool

entertainment

fashion

leisure time

Cancer drug shortages should be causing more outrage

FogPharma raises $145 million in rare Series E round

Cancer drug shortages should be causing more outrage

Smaller biotechs seek to piggyback on weight loss drug boom

As demand for Covid shots wanes, Moderna seeks its next success

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Drug repurposing or repositioning? The language matters

STAT Readout: Friday, Oct. 20 biotech updates

New air purifier tech could be key to improving indoor air quality

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

knowledge

FogPharma raises $145 million in rare Series E round

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

In search for therapies for solid tumors, companies turn to claudin

The problems with dementia villages

Medical device lobby: We're tired of waiting on Medicare coverage

ADCs take center stage as promising cancer treatments

explore

leisure time

entertainment

entertainment